by
Lauren Postlewait;
Cecilia G Ethun;
Mia R McInnis;
Nipun Merchant;
Alexander Parikh;
Kamran Idrees;
Chelsea A Isom;
William Hawkins;
Ryan C Fields;
Matthew Strand;
Sharon M Weber;
Clifford S Cho;
Ahmed Salem;
Robert CG Martin;
Charles Scoggins;
David Bentrem;
Hong J Kim;
Jacquelyn Carr;
Syed Ahmad;
Daniel Abbott;
Gregory C Wilson;
David Kooby;
Shishir Maithel
Pancreatic mucinous cystic neoplasms (MCNs) are rare tumors typically of the distal pancreas that harbor malignant potential. Although resection is recommended, data are limited on optimal operative approaches to distal pancreatectomy for MCN. MCN resections (2000–2014; eight institutions) were included. Outcomes of minimally invasive and open MCN resections were compared. A total of 289 patients underwent distal pancreatectomy for MCN: 136(47%) minimally invasive and 153(53%) open. Minimally invasive procedures were associated with smaller MCN size (3.9 vs 6.8 cm; P 5 0.001), lower operative blood loss (192 vs 392 mL; P 5 0.001), and shorter hospital stay(5 vs 7 days; P 5 0.001) compared with open. Despite higher American Society of Anesthesiologists class, hand-assisted (n 5 46) had similar advantages as laparoscopic/robotic (n 5 76). When comparing hand-assisted to open, although MCN size was slightly smaller (4.1 vs 6.8 cm; P 5 0.001), specimen length, operative time, and nodal yield were identical. Similar to laparoscopic/robotic, hand-assisted had lower operative blood loss (161 vs 392 mL; P 5 0.001) and shorter hospital stay (5 vs 7 days; P 5 0.03) compared with open, without increased complications. Hand-assisted laparoscopic technique is a useful approach for MCN resection because specimen length, lymph node yield, operative time, and complication profiles are similar to open procedures, but it still offers the advantages of a minimally invasive approach. Hand-assisted laparoscopy should be considered as an alternative to open technique or as a successive step before converting from total laparoscopic to open distal pancreatectomy for MCN.
by
Lyndsey J Kilgore;
Brittany L Murphy;
Lauren Postlewait;
Diana H Liang;
Isabelle Bedrosian;
Anthony Lucci;
Henry M Kuerer;
Kelly K Hunt;
Mediget Teshome
Introduction: The early COVID-19 pandemic rapidly transformed healthcare and medical education. We sought to evaluate the professional and personal impact of the pandemic on 2019–2020 Breast Surgical Oncology (BSO) fellows in Society of Surgical Oncology approved programs to capture the experience and direct future changes. Methods: From July 15, 2020 to August 4, 2020 a survey was administered to the American Society of Breast Surgeons' fellow members. The survey assessed the impact of the pandemic on clinical experience, education/research opportunities, personal health/well-being, and future career. Responses were collected and aggregated to quantify the collective experience of respondents. Results: Twenty-eight of fifty-seven (54%) eligible fellows responded. Twenty-one (75%) indicated the clinical experience changed. Twenty-seven (96%) reported less time spent caring for ambulatory breast patients and sixteen (57%) reported the same/more time spent in the operating room. Fourteen (50%) stated their future job was impacted and eight (29%) delayed general surgery board examinations. Stress was increased in 26 (93%). Personal health was unaffected in 20 (71%), and 3 (10%) quarantined for COVID-19 exposure/infection. Conclusion: The COVID-19 pandemic altered the clinical experience of BSO fellows; however, the operative experience was generally unaffected. The creation of frameworks and support mechanisms to mitigate potential challenges for fellows and fellowship programs in the ongoing pandemic and other times of national crisis should be considered.